Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy
S Furness, AM Glenny, HV Worthington… - Cochrane Database …, 2011 - cochranelibrary.com
Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …
Head and neck cancers
DG Pfister, KK Ang, DM Brizel, BA Burtness… - Journal of the National …, 2011 - jnccn.org
Head and Neck Cancers in: Journal of the National Comprehensive Cancer Network Volume
9 Issue 6 (2011) Jump to Content User Account Sign In to save searches and organize your …
9 Issue 6 (2011) Jump to Content User Account Sign In to save searches and organize your …
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced …
R Haddad, A O'Neill, G Rabinowits, R Tishler… - The Lancet …, 2013 - thelancet.com
Background The relative efficacy of the addition of induction chemotherapy to
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of …
P Blanchard, J Bourhis, B Lacas, MR Posner… - Journal of clinical …, 2013 - ascopubs.org
Purpose Cisplatin plus fluorouracil (PF) induction chemotherapy has been compared with
taxane (docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in …
taxane (docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in …
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell …
Background Induction chemotherapy with docetaxel, cisplatin and 5 FU (TPF) before
radiotherapy (RT) or radio-chemotherapy (RT-CHX) has been shown to improve overall …
radiotherapy (RT) or radio-chemotherapy (RT-CHX) has been shown to improve overall …
Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or …
J Ma, Y Liu, XL Huang, ZY Zhang, JN Myers… - Oral oncology, 2012 - Elsevier
The definitive effect of induction chemotherapy (IC) on locally advanced head and neck
squamous cell carcinoma (HNSCC) remains uncertain and although randomized controlled …
squamous cell carcinoma (HNSCC) remains uncertain and although randomized controlled …
[HTML][HTML] Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription
I Brana, LL Siu - Annals of Oncology, 2012 - Elsevier
Despite the policy changes to decrease tobacco consumption and therapeutic advances in
this disease, squamous cell carcinomas arising from the head and neck (HNSCC) continue …
this disease, squamous cell carcinomas arising from the head and neck (HNSCC) continue …
Ten years of progress in head and neck cancers
Squamous cell carcinoma of the head and neck (HNSCC) is a heterogenous disease
characterized by complex clinical and pathologic presentations constituting approximately …
characterized by complex clinical and pathologic presentations constituting approximately …
Induction chemotherapy for head and neck cancer: recent data
EE Vokes - The oncologist, 2010 - academic.oup.com
The addition of chemotherapy to radiotherapy in the treatment of locally advanced
squamous cell carcinoma of the head and neck (SCCHN) patients improves survival. Meta …
squamous cell carcinoma of the head and neck (SCCHN) patients improves survival. Meta …
Chemotherapy for nasopharyngeal carcinoma–current recommendation and controversies
H Sze, P Blanchard, WT Ng… - Hematology …, 2015 - hemonc.theclinics.com
Nasopharyngeal carcinoma (NPC) has a peculiarly skewed distribution; this is a rare cancer
in North America but highly prevalent in Southeast Asia. The classical nonkeratinizing type …
in North America but highly prevalent in Southeast Asia. The classical nonkeratinizing type …